Ulipristal Acetate (CDB 2914)

Synonyms: HRP 2000, RU 44675

Ulipristal acetate (CDB-2914, HRP 2000, RU 44675) is a selective SPRM for emergency contraception after an unprotected intercourse or contraceptive failure.

Ulipristal Acetate (CDB 2914) Chemical Structure

Ulipristal Acetate (CDB 2914) Chemical Structure

CAS: 126784-99-4

Selleck's Ulipristal Acetate (CDB 2914) has been cited by 2 publications

Purity & Quality Control

Batch: Purity: 99.95%
99.95

Ulipristal Acetate (CDB 2914) Related Products

Choose Selective Estrogen/progestogen Receptor Inhibitors

Biological Activity

Description Ulipristal acetate (CDB-2914, HRP 2000, RU 44675) is a selective SPRM for emergency contraception after an unprotected intercourse or contraceptive failure.
Targets
Progesterone receptor [1]
In vitro
In vitro Ulipristal acetate has partial agonistic as well as antagonistic effects on the progesterone receptor. It also binds to theglucocorticoid receptor, but has no relevant affinity to the estrogen, androgen and mineralocorticoid receptors.[1]
In Vivo
In vivo Based on clinical trials, ulipristal acetate seems to be a reasonably tolerable and effective method of emergency contraception when used within 120 hours of intercourse. Ulipristal acetate is at least as effective as LNG when used within the first 72 hours after unprotected intercourse. However, ulipristal acetate may be more effective than LNG when used between 72 to 120 hours after unprotected intercourse, extending the window of opportunity for emergency contraception. [2][3]
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03349190 Completed
Infertility Female|Fibroid Uterus
ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO|Gedeon Richter Plc.
December 29 2017 --
NCT03118297 Completed
Contraception|Bleeding
Washington University School of Medicine
May 1 2017 Phase 3
NCT03156127 Withdrawn
Uterine Myoma
Boryung Pharmaceutical Co. Ltd
May 19 2017 Phase 1
NCT02408770 Completed
Breast Cancer
Manchester University NHS Foundation Trust|University of Manchester
January 22 2016 Phase 2
NCT02634437 Completed
Renal Function
Allergan
December 1 2015 Phase 1

Chemical Information & Solubility

Molecular Weight 475.62 Formula

C30H37NO4

CAS No. 126784-99-4 SDF Download Ulipristal Acetate (CDB 2914) SDF
Smiles CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 83 mg/mL ( (174.5 mM); Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 14 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ulipristal Acetate (CDB 2914) | Ulipristal Acetate (CDB 2914) ic50 | Ulipristal Acetate (CDB 2914) price | Ulipristal Acetate (CDB 2914) cost | Ulipristal Acetate (CDB 2914) solubility dmso | Ulipristal Acetate (CDB 2914) purchase | Ulipristal Acetate (CDB 2914) manufacturer | Ulipristal Acetate (CDB 2914) research buy | Ulipristal Acetate (CDB 2914) order | Ulipristal Acetate (CDB 2914) mouse | Ulipristal Acetate (CDB 2914) chemical structure | Ulipristal Acetate (CDB 2914) mw | Ulipristal Acetate (CDB 2914) molecular weight | Ulipristal Acetate (CDB 2914) datasheet | Ulipristal Acetate (CDB 2914) supplier | Ulipristal Acetate (CDB 2914) in vitro | Ulipristal Acetate (CDB 2914) cell line | Ulipristal Acetate (CDB 2914) concentration | Ulipristal Acetate (CDB 2914) nmr